Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Prolonged response to anti-tumour necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis.

Seymour MW, Home DM, Williams RO, Allard SA.

Rheumatology (Oxford). 2007 Nov;46(11):1738-9. Epub 2007 Oct 12. No abstract available.

PMID:
17933796
2.

Sustained response to tocilizumab, anti-IL-6 antibody, following anti-TNF-α failure in a patient with relapsing polychondritis complicated by aortitis.

Narshi CB, Allard SA.

Rheumatology (Oxford). 2012 May;51(5):952-3. doi: 10.1093/rheumatology/ker451. Epub 2012 Jan 31. No abstract available.

PMID:
22298790
3.

Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab.

Mpofu S, Estrach C, Curtis J, Moots RJ.

Rheumatology (Oxford). 2003 Sep;42(9):1117-8. No abstract available.

PMID:
12923271
4.

The successful use of infliximab in resistant relapsing polychondritis and associated scleritis.

Cazabon S, Over K, Butcher J.

Eye (Lond). 2005 Feb;19(2):222-4. No abstract available.

PMID:
15258602
5.

Fatal acute necrotizing eosinophilic myocarditis temporally related to use of adalimumab in a patient with relapsing polychondritis.

Adamson R, Yazici Y, Katz ES, Greisman SG, Steiger D.

J Clin Rheumatol. 2013 Oct;19(7):386-9. doi: 10.1097/RHU.0b013e3182a701cb.

PMID:
24048108
6.

Treatment of relapsing polychondritis with the TNF-alpha antagonist adalimumab.

Lahmer T, Knopf A, Treiber M, Heemann U, Thuermel K.

Clin Rheumatol. 2010 Nov;29(11):1331-4. doi: 10.1007/s10067-010-1488-1. Epub 2010 May 22.

PMID:
20495939
7.

Relapsing polychondritis: a new adverse event secondary to the use of tumour necrosis factor antagonists?

Hernández MV, Ruiz-Esquide V, Gómez-Caballero ME, Gómez-Puerta JA, Cañete JD, Sanmartí R.

Rheumatology (Oxford). 2011 Aug;50(8):1523-5. doi: 10.1093/rheumatology/ker144. Epub 2011 May 18. No abstract available.

PMID:
21593064
8.

Successful treatment of relapsing polychondritis with infliximab.

Richez C, Dumoulin C, Coutouly X, Schaeverbeke T.

Clin Exp Rheumatol. 2004 Sep-Oct;22(5):629-31.

PMID:
15485019
9.

Sustained remission of pediatric relapsing polychondritis with adalimumab.

Navarrete VM, Lebrón CV, de Miera FJ, Candau CP, Sarabia FN.

J Clin Rheumatol. 2014 Jan;20(1):45-6. doi: 10.1097/RHU.0000000000000063. No abstract available.

PMID:
24356482
10.
11.

Adalimumab: an anti-TNF agent for the treatment of psoriatic arthritis.

Mease PJ.

Expert Opin Biol Ther. 2005 Nov;5(11):1491-504. Review.

PMID:
16255652
13.

Treatment of relapsing polychondritis with a TNF antagonist.

Carter JD.

J Rheumatol. 2005 Jul;32(7):1413. No abstract available.

14.

A case of severe MAGIC syndrome treated successfully with the tumor necrosis factor-alpha inhibitor infliximab.

Geissal ED, Wernick R.

J Clin Rheumatol. 2010 Jun;16(4):185-7. doi: 10.1097/RHU.0b013e3181dfce16.

PMID:
20414125
15.
16.

Use of adalimumab in poststreptococcal reactive arthritis.

Sánchez-Cano D, Callejas-Rubio JL, Ortego-Centeno N.

J Clin Rheumatol. 2007 Jun;13(3):176. No abstract available.

PMID:
17551391
17.

Sustained response to infliximab in a patient with relapsing polychondritis with aortic involvement.

Marie I, Lahaxe L, Josse S, Levesque H.

Rheumatology (Oxford). 2009 Oct;48(10):1328-9. doi: 10.1093/rheumatology/kep224. Epub 2009 Aug 3. No abstract available.

PMID:
19651886
18.

Adalimumab for rheumatoid arthritis?

Ebell M, Kripke C.

Am Fam Physician. 2006 Feb 1;73(3):435-6. Review. No abstract available.

19.

Adalimumab in juvenile rheumatoid arthritis.

de Vries MK, van der Horst-Bruinsma IE, Wolbink GJ.

N Engl J Med. 2008 Dec 4;359(23):2496; author reply 2496-7. No abstract available.

PMID:
19065700
20.

Sweet's syndrome after adalimumab therapy for refractory relapsing polychondritis.

Keidel S, McColl A, Edmonds S.

BMJ Case Rep. 2011 Dec 21;2011. pii: bcr1020114935. doi: 10.1136/bcr.10.2011.4935.

Supplemental Content

Support Center